U.S. markets close in 3 hours 21 minutes
  • S&P 500

    3,965.67
    -123.18 (-3.01%)
     
  • Dow 30

    31,823.49
    -831.10 (-2.55%)
     
  • Nasdaq

    11,554.91
    -429.62 (-3.58%)
     
  • Russell 2000

    1,785.92
    -54.38 (-2.95%)
     
  • Crude Oil

    109.88
    -2.52 (-2.24%)
     
  • Gold

    1,819.00
    +0.10 (+0.01%)
     
  • Silver

    21.60
    -0.15 (-0.69%)
     
  • EUR/USD

    1.0496
    -0.0059 (-0.56%)
     
  • 10-Yr Bond

    2.9110
    -0.0570 (-1.92%)
     
  • GBP/USD

    1.2383
    -0.0110 (-0.88%)
     
  • USD/JPY

    128.2820
    -1.0760 (-0.83%)
     
  • BTC-USD

    29,098.51
    -982.95 (-3.27%)
     
  • CMC Crypto 200

    650.92
    -19.76 (-2.95%)
     
  • FTSE 100

    7,438.09
    -80.26 (-1.07%)
     
  • Nikkei 225

    26,911.20
    +251.45 (+0.94%)
     

Better Buy: IBM vs. Kyndryl

·5 min read
Better Buy: IBM vs. Kyndryl
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Last November, IBM (NYSE: IBM) completed its spin-off of Kyndryl (NYSE: KD), the managed infrastructure services segment of its Global Technology Services segment. Each IBM shareholder received one new share of Kyndryl for every five shares of IBM they held. IBM still retained 20% of Kyndryl's outstanding shares following the spin-off, but it plans to sell that entire stake this year.